Immunotherapy Indications Withdrawn In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs? by Anna Goshua New Tactics for Bladder Cancer After decades without treatment advances, options for patients with bladder cancer are now more numerous. by Kendall K. Morgan Survivor Profile Hope and Endurance Bladder cancer survivor Randy Layne and his wife, Ellen, faced his diagnosis, treatment and recovery together. by Martha Irvine Yesterday & Today Who Loves Ya, Baby? Telly Savalas met his match in bladder cancer. Earlier diagnosis and more aggressive treatment might have made a difference. by Jocelyn Selim Cancer Talk Exercise, Cancer and Aging A study on aging shows that cancer survivors are at higher risk of losing strength and walking more slowly compared to those with no cancer history. Exercise is one way to combat this decline by Marcus A. Banks Preconceived Notions: Cancer, Fertility Coverage and the Law Insurance coverage for fertility treatments is not mandated by federal law, although some states require it. People seeking cancer treatment need to understand their coverage and the law in their state. by Shelly Rosenfeld Drug Delays Recurrence in People With Early-Stage Breast Cancer People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor. by Pamela Rafalow Grossman Open Medical Records: Pros and Cons Patients now have full access to their online medical records. What are the benefits and downsides? by Jen Tota McGivney More Posts